Results
|
|
241.
|
|
|
|
242.
|
|
|
|
243.
|
A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403. [electronic resource] by
- Oda, Naohiro
- Hotta, Kastuyuki
- Ninomiya, Kiichiro
- Minami, Daisuke
- Ichihara, Eiki
- Murakami, Toshi
- Yokoyama, Toshihide
- Ichikawa, Hirohisa
- Chikamori, Kenichi
- Takigawa, Nagio
- Ochi, Nobuaki
- Harita, Shingo
- Maeda, Yoshinobu
- Kiura, Katsuyuki
Producer: 20190828
In:
Cancer chemotherapy and pharmacology vol. 82
Availability: No items available.
|
|
|
244.
|
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance [electronic resource] by
- Starrett, Jacqueline H
- Guernet, Alexis A
- Cuomo, Maria Emanuela
- Poels, Kamrine E
- van Alderwerelt van Rosenburgh, Iris K
- Nagelberg, Amy
- Farnsworth, Dylan
- Price, Kristin S
- Khan, Hina
- Ashtekar, Kumar Dilip
- Gaefele, Mmaserame
- Ayeni, Deborah
- Stewart, Tyler F
- Kuhlmann, Alexandra
- Kaech, Susan M
- Unni, Arun M
- Homer, Robert
- Lockwood, William W
- Michor, Franziska
- Goldberg, Sarah B
- Lemmon, Mark A
- Smith, Paul D
- Cross, Darren A E
- Politi, Katerina
Producer: 20201026
In:
Cancer research vol. 80
Availability: No items available.
|
|
|
245.
|
|
|
|
246.
|
|
|
|
247.
|
An Acquired [electronic resource] by
- Hanker, Ariella B
- Brewer, Monica Red
- Sheehan, Jonathan H
- Koch, James P
- Sliwoski, Gregory R
- Nagy, Rebecca
- Lanman, Richard
- Berger, Michael F
- Hyman, David M
- Solit, David B
- He, Jie
- Miller, Vincent
- Cutler, Richard E
- Lalani, Alshad S
- Cross, Darren
- Lovly, Christine M
- Meiler, Jens
- Arteaga, Carlos L
Producer: 20180306
In:
Cancer discovery vol. 7
Availability: No items available.
|
|
|
248.
|
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial. [electronic resource] by
- Paz-Ares, L
- Tan, E-H
- O'Byrne, K
- Zhang, L
- Hirsh, V
- Boyer, M
- Yang, J C-H
- Mok, T
- Lee, K H
- Lu, S
- Shi, Y
- Lee, D H
- Laskin, J
- Kim, D-W
- Laurie, S A
- Kölbeck, K
- Fan, J
- Dodd, N
- Märten, A
- Park, K
Producer: 20171225
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
249.
|
|
|
|
250.
|
Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations. [electronic resource] by
- Tanaka, Ichidai
- Morise, Masahiro
- Kodama, Yuta
- Matsui, Akira
- Ozawa, Naoya
- Ozone, Sachiko
- Goto, Daiki
- Miyazawa, Ayako
- Hase, Tetsunari
- Hashimoto, Naozumi
- Sato, Mitsuo
- Hasegawa, Yoshinori
Producer: 20191227
In:
Lung cancer (Amsterdam, Netherlands) vol. 127
Availability: No items available.
|
|
|
251.
|
Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study. [electronic resource] by
- Ho, Gwo-Fuang
- Chai, Chee-Shee
- Alip, Adlinda
- Wahid, Mohd Ibrahim A
- Abdullah, Matin Mellor
- Foo, Yoke-Ching
- How, Soon-Hin
- Zaatar, Adel
- Lam, Kai-Seng
- Leong, Kin-Wah
- Low, John-Seng-Hooi
- Yusof, Mastura Md
- Lee, Erica Chai-Yong
- Toh, Yok-Yong
- Liam, Chong-Kin
Producer: 20200228
In:
BMC cancer vol. 19
Availability: No items available.
|
|
|
252.
|
A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402). [electronic resource] by
- Yokoyama, Toshihide
- Yoshioka, Hiroshige
- Fujimoto, Daichi
- Demura, Yoshiki
- Hirano, Katsuya
- Kawai, Takahiro
- Kagami, Ryogo
- Washio, Yasuyoshi
- Ishida, Tadashi
- Kogo, Mariko
- Tomii, Keisuke
- Okuno, Takehiro
- Akai, Masaya
- Hirabayashi, Masataka
- Nishimura, Takashi
- Nakahara, Yasuharu
- Kim, Young Hak
- Miyakoshi, Chisato
- Yoshimura, Kenichi
- Hirai, Toyohiro
Producer: 20200713
In:
Lung cancer (Amsterdam, Netherlands) vol. 135
Availability: No items available.
|
|
|
253.
|
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer. [electronic resource] by
- Molife, L Rhoda
- Omlin, Aurelius
- Jones, Rob J
- Karavasilis, Vasilios
- Bloomfield, David
- Lumsden, Graeme
- Fong, Peter C
- Olmos, David
- O'Sullivan, Joe M
- Pedley, Ian
- Hickish, Tamas
- Jenkins, Peter
- Thompson, Emilda
- Oommen, Nikhil
- Wheatley, Duncan
- Heath, Catherine
- Temple, Graham
- Pelling, Katy
- de Bono, Johann S
Producer: 20140925
In:
Future oncology (London, England) vol. 10
Availability: No items available.
|
|
|
254.
|
|
|
|
255.
|
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation. [electronic resource] by
- Hoshi, Hirotaka
- Hiyama, Gen
- Ishikawa, Kosuke
- Inageda, Kiyoshi
- Fujimoto, Jiro
- Wakamatsu, Ai
- Togashi, Takushi
- Kawamura, Yoshifumi
- Takahashi, Nobuhiko
- Higa, Arisa
- Goshima, Naoki
- Semba, Kentaro
- Watanabe, Shinya
- Takagi, Motoki
Producer: 20170410
In:
Oncology reports vol. 37
Availability: No items available.
|
|
|
256.
|
|
|
|
257.
|
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinoma. [electronic resource] by
- Chung, Christine H
- Rudek, Michelle A
- Kang, Hyunseok
- Marur, Shanthi
- John, Pritish
- Tsottles, Nancy
- Bonerigo, Sarah
- Veasey, Andy
- Kiess, Ana
- Quon, Harry
- Cmelak, Anthony
- Murphy, Barbara A
- Gilbert, Jill
Producer: 20161213
In:
Oral oncology vol. 53
Availability: No items available.
|
|
|
258.
|
|
|
|
259.
|
|
|
|
260.
|
|